Ten-year patient survival on maintenance haemodialysis: association with treatment time and dialysis dose

    loading  Checking for direct PDF access through Ovid



Analyses of national registry-based datasets have demonstrated the association of longer haemodialysis treatment times with lowered mortality risk.


We performed a prospective cohort study of 451 incident haemodialysis patients and examined the effect of targeting higher dialysis dose with extended treatment time, on 10-year patient outcomes.


Mean treatment time (TT) was 233 ± 22.8 minutes (median 235, range 180-296). Overall patient survival was 95% at 1 year, 75% at 3 years, 56% at 5 years and 25% at 10 years. Increasing TT was associated with incremental 10-year patient survival (TT ≥241 minutes 39.7%, TT 226-240 minutes 19.6% and TT ≤225 minutes 14.7%; p<0.001). Single pool Kt/V and TT were strong independent predictors of patient survival in Cox multivariate analysis (p<0.0001). At 10 years, each 0.1-unit increase in spKt/V and 20-minute increase in TT were associated with a 20% and 32% decrease in the relative risk of death, respectively. Survival benefits of higher dialysis dose and longer TT were cumulative, with highest survival exhibited by patients achieving both Kt/V >1.6 and TT ≥241 minutes, and lowest survival exhibited by patients receiving Kt/V <1.2 and TT ≤225 minutes.


Extended treatment times are associated with higher patient survival irrespective of dialysis dose. Further study of extended treatment time and effect on patient outcomes is needed.

Related Topics

    loading  Loading Related Articles